Cellbox Solutions Closes €5 Mn Series A to Expand Warm-Chain Logistics

The company will use the funding to develop its business and expand its services. It also plans to offer integrated logistics solutions for transporting sensitive biological materials.

“Over the past years, we have built a strong foundation for the controlled transport of living biological materials,” says Prof. Dr. Kathrin Adlkofer, founder and CEO of Cellbox Solutions. “With the successful completion of our Series A round, we are now expanding our established warm-chain technology platform into a broader offering for physiological logistics. This will allow us to support customers more comprehensively across their logistics workflows and expand our presence in key international markets.”

“Completion of the Series A gives us additional resources to scale the commercial model behind our technology. By expanding rental and recurring service offerings and combining them with transportation, monitoring, and complementary logistics services, we can build longer-term customer relationships and a more scalable service model across markets. Our focus is now on translating the strength of the Cellbox platform into sustainable commercial growth,” adds Dr. Bernd Muehlenweg, CBO and CFO of Cellbox Solutions.

Founded in 2017, Cellbox Solutions is a Cologne-based company in Germany that provides transport solutions for the healthcare and life sciences industries.

The company helps transport sensitive biological materials and medical treatments that cannot be frozen and need carefully controlled conditions to remain safe.

Its portable Cellbox system works like a small CO₂ incubator, creating a controlled environment for transporting living cells, organoids, tissues and other advanced biological materials.

The system allows users to adjust temperature and CO₂ levels to maintain the right conditions during transport. Cellbox solutions are used worldwide for research, clinical studies and advanced medical treatments.

Read Also- Coherence Quantum Raises €2.78 Mn in Seed Funding to Advance Quantum Computing Technology